Industry News 2019-02-14T03:28:07+00:00

Industry News

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

Duke DCRI joins the Digital Therapeutics Alliance

May 15, 2019 – The DCRI will bring its regulatory experience and clinical expertise to the conversation surrounding digital therapeutics. The DCRI has joined a new alliance focused on bringing digital therapeutics solutions to patients. [...]

Digital Therapeutics Need Quality Standards

Forbes (Greg Licholai) - Quality standards are necessary to help promote adoption of the novel class of interventions called digital therapeutics. This rapidly emerging industry needs to bring together regulators, engineers, practitioners, and companies to [...]

Digital Therapeutics Alliance boosts European presence

DUBLIN, IRELAND - 16 October 2018 - S3 Connected Health News - Digital Therapeutics Alliance (DTA) boosts Europe presence to advance the adoption of evidence-based digital therapeutics S3 Connected Health, a DTA member, is working alongside fellow [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

Pharma execs are bullish on digital therapeutics

Nicky Lineaweaver/Business Insider - Digital therapeutics has caught the eye of pharmaceutical companies as a potential balm to a host of the pharma industry's struggles, according to MedCity News. Digital therapeutics is a category of software — [...]

Load More Posts

DTx Research & Studies

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Impact of a digital health intervention on asthma resource utilization

Digital health interventions have been associated with reduced rescue inhaler use and improved controller medication adherence. This quality improvement project assessed the benefit of these interventions on asthma-related healthcare utilizations, including hospitalizations, emergency department (ED) [...]

Use of Digital Health Technology to Enable Drug Development

This pilot study developed and evaluated the feasibility, usability, and perceived satisfaction with an end-user mobile medical application and provider web portal. The two interfaces allowed for remote monitoring, provided daily guidance in the management [...]

Load More Posts

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now